Facetten
Zugriff
Einrichtung
Medientyp
- Text 13
Karte
Erscheinungsjahr
Autor/in
- Bokemeyer, Carsten
- Ludwig, Heinz
- Aapro, Matti 9
- Abraham, Ivo 9
- MacDonald, Karen 7
- alle zeigen
Sprache
13 Einträge gefunden
-
Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study
- Ludwig, Heinz
- Bokemeyer, Carsten
- Aapro, Matti
- Boccadoro, Mario
- Gascón, Pere
- Denhaerynck, Kris
- Krendyukov, Andriy
-
Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" ( 72 h): findings from the MONITOR-GCSF study
- Ludwig, Heinz
- Gascón, Pere
- Bokemeyer, Carsten
- Aapro, Matti
- Boccadoro, Mario
- Denhaerynck, Kris
- Krendyukov, Andriy
-
Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study
- Bokemeyer, Carsten
- Gascón, Pere
- Aapro, Matti
- Ludwig, Heinz
- Boccadoro, Mario
- Denhaerynck, Kris
- Gorray, Michael
-
Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)
- Aapro, Matti
- Bokemeyer, Carsten
- Ludwig, Heinz
- Gascón, Pere
- Boccadoro, Mario
- Denhaerynck, Kris
- Gorray, Michael
-
Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)
- Gascón, Pere
- Aapro, Matti
- Ludwig, Heinz
- Bokemeyer, Carsten
- Boccadoro, Mario
- Turner, Matthew
- Denhaerynck, Kris
-
Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)
- Gascón, Pere
- Aapro, Matti
- Ludwig, Heinz
- Bokemeyer, Carsten
- Boccadoro, Mario
- Turner, Matthew
- Denhaerynck, Kris
-
Modeling of treatment response to erythropoiesis-stimulating agents in older (age≥70years) and younger (age<70years) patients with cancer and anemia: findings from the Anemia Cancer Treatment study
- Abraham, Ivo
- MacDonald, Karen
- Tharmarajah, Soba
- Bokemeyer, Carsten
- Ludwig, Heinz
- Soubeyran, Pierre
- Battistel, Vittorio
-
Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.
- Canon, Jean-Luc
- Vansteenkiste, Johan
- Hedenus, Michael
- Gascon, Pere
- Bokemeyer, Carsten
- Ludwig, Heinz
- Vermorken, Jan
-
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.
- Ludwig, Heinz
- Aapro, Matti
- Bokemeyer, Carsten
- Macdonald, Karen
- Soubeyran, Pierre
- Turner, Matthew
- Albrecht, Tara
-
Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level <10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial.
- Vansteenkiste, Johan
- Hedenus, Michael
- Gascon, Pere
- Bokemeyer, Carsten
- Ludwig, Heinz
- Vermorken, Jan
- Hamilton, Lisa
-
-
Erythropoietins should be used according to guidelines.
- Aapro, Matti S
- Birgegård, Gunnar
- Bokemeyer, Carsten
- Cornes, Paul
- Foubert, Jan
- Gascon, Pere
- Glaspy, John
-
The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines.
- Aapro, Matti
- Abraham, Ivo
- Bokemeyer, Carsten
- Ludwig, Heinz
- Macdonald, Karen
- Soubeyran, Pierre
- Turner, Matthew